EGFR and neoplasm: Studies found a significant association between the tumor uptake of copper-64 (64Cu) labeled cetuximab ([64Cu]Cu-DOTA-cetuximab) and the expression levels of EGFR protein in cervical cancer cell lines [11] and in xenograft mouse models with various cancer types [12, 13].